CPIX Cumberland Pharmaceuticals Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: CPIX

Price (delayed)

$1.7

Market cap

$24.1M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.44

Enterprise value

$24.21M

Cumberland Emerging Technologies, Inc.(www.cet-fund.com)is a joint initiative between Cumberland Pharmaceuticals Inc., Vanderbilt University, LaunchTN and WinHealth Pharma. The mission of CET is to bring biomedical technologies and products conceived at ...

Highlights
The company's debt fell by 12% YoY
The gross margin has increased by 8% YoY and by 3.7% QoQ
Cumberland Pharmaceuticals's EPS has plunged by 159% from the previous quarter and by 16% YoY
The net income has shrunk by 159% QoQ and by 13% YoY
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: http://www.cumberlandpharma.com
Peers: DRRX IRWD MRK PFE

Key stats

What are the main financial stats of CPIX
Market
Shares outstanding
14.18M
Market cap
$24.1M
Enterprise value
$24.21M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.82
Price to sales (P/S)
0.61
EV/EBIT
N/A
EV/EBITDA
118.22
EV/Sales
0.61
Earnings
Revenue
$39.55M
EBIT
-$5.57M
EBITDA
$204,764
Free cash flow
$5.64M
Per share
EPS
-$0.44
Free cash flow per share
$0.39
Book value per share
$2.08
Revenue per share
$2.77
TBVPS
$4.07
Balance sheet
Total assets
$81.78M
Total liabilities
$52.52M
Debt
$18.43M
Equity
$29.6M
Working capital
$7.73M
Liquidity
Debt to equity
0.62
Current ratio
1.28
Quick ratio
1
Net debt/EBITDA
0.52
Margins
EBITDA margin
0.5%
Gross margin
84.7%
Net margin
-15.9%
Operating margin
-24.2%
Efficiency
Return on assets
-7.2%
Return on equity
-18.1%
Return on invested capital
-16.5%
Return on capital employed
-10.3%
Return on sales
-14.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CPIX stock price

How has the Cumberland Pharmaceuticals stock price performed over time
Intraday
5.59%
1 week
3.03%
1 month
-0.58%
1 year
-9.57%
YTD
-5.12%
QTD
1.19%

Financial performance

How have Cumberland Pharmaceuticals's revenue and profit performed over time
Revenue
$39.55M
Gross profit
$33.49M
Operating income
-$9.55M
Net income
-$6.28M
Gross margin
84.7%
Net margin
-15.9%
The net income has shrunk by 159% QoQ and by 13% YoY
The company's net margin has shrunk by 156% QoQ and by 20% YoY
The company's operating margin has shrunk by 78% YoY and by 68% QoQ
CPIX's operating income has dropped by 69% since the previous quarter and by 67% year-on-year

Growth

What is Cumberland Pharmaceuticals's growth rate over time

Valuation

What is Cumberland Pharmaceuticals stock price valuation
P/E
N/A
P/B
0.82
P/S
0.61
EV/EBIT
N/A
EV/EBITDA
118.22
EV/Sales
0.61
Cumberland Pharmaceuticals's EPS has plunged by 159% from the previous quarter and by 16% YoY
CPIX's P/B is 25% below its 5-year quarterly average of 1.1 but 17% above its last 4 quarters average of 0.7
CPIX's equity is down by 18% year-on-year and by 18% since the previous quarter
The stock's price to sales (P/S) is 56% less than its 5-year quarterly average of 1.4
The revenue has contracted by 6% YoY

Efficiency

How efficient is Cumberland Pharmaceuticals business performance
The company's return on equity has shrunk by 170% QoQ and by 27% YoY
The ROA has plunged by 167% from the previous quarter and by 20% YoY
Cumberland Pharmaceuticals's ROS has decreased by 21% YoY
CPIX's return on invested capital is down by 18% year-on-year

Dividends

What is CPIX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CPIX.

Financial health

How did Cumberland Pharmaceuticals financials performed over time
The total assets is 56% greater than the total liabilities
The current ratio is down by 20% year-on-year and by 16% since the previous quarter
The quick ratio has decreased by 13% YoY and by 12% QoQ
The company's debt is 38% lower than its equity
The debt to equity has grown by 19% from the previous quarter and by 7% YoY
CPIX's equity is down by 18% year-on-year and by 18% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.